8-KOther EventsExhibits & Filings

Cencora, Inc. 8-K Report, Corporate Update (Jun 27, 2014)

Filed June 27, 2014For Securities:COR

Summary

AmerisourceBergen Corporation (now Cencora, Inc.) announced on June 26, 2014, the completion of a significant strategic transaction involving Profarma Distribuidora de Produtos Farmacêuticos S.A. This move includes acquiring a minority stake of approximately 19.9% in Profarma for about $110 million. This investment signifies AmerisourceBergen's expansion into the Brazilian pharmaceutical market and aims to leverage Profarma's established presence. Furthermore, AmerisourceBergen and Profarma have formed a joint venture, with AmerisourceBergen holding a 50% stake. This joint venture is specifically designed to enhance specialty distribution and services within Brazil. While a substantial investment, the company indicated that this transaction is not expected to have a material impact on its adjusted earnings per share for the fiscal year 2014.

Key Highlights

  • 1AmerisourceBergen acquired a 19.9% minority stake in Profarma for approximately $110 million.
  • 2A 50% stake in a new specialty joint venture with Profarma was also established.
  • 3The transaction expands AmerisourceBergen's presence into the Brazilian pharmaceutical market.
  • 4The joint venture aims to enhance specialty distribution and services in Brazil.
  • 5The company does not anticipate a material impact on its fiscal 2014 adjusted EPS from this transaction.

Frequently Asked Questions

The primary purpose of this 8-K filing was to announce AmerisourceBergen Corporation's completion of the acquisition of a minority stake in Profarma Distribuidora de Produtos Farmacêuticos S.A. and the launch of a joint venture with Profarma.

AmerisourceBergen stated that it does not expect the transaction to have a meaningful impact on its adjusted earnings per share from continuing operations for fiscal 2014.

This deal represents a strategic expansion for AmerisourceBergen into the Brazilian market, allowing it to enhance its specialty distribution and services capabilities through a partnership with Profarma.

AmerisourceBergen invested a total of approximately $110 million, which includes the investment for the minority stake in Profarma and its share of the joint venture.